| [1] |
Jiang Y, Du F, Chen F, et al. Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population [J]. Mol Carcinog, 2017, 56(9): 2048-2057.
|
| [2] |
Akram M, Iqbal M, Daniyal M, et al. Awareness and current knowledge of breast cancer [J]. Biol Res, 2017, 50(1): 33.
|
| [3] |
Desantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(6): 438-451.
|
| [4] |
刘月，杨强，宁守斌. 长链非编码RNA在肿瘤发生发展中作用机制的研究 [J]. 空军医学杂志，2016, 32(2): 136-138.
|
| [5] |
Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes [J]. Science, 2010, 329(5992): 689-693.
|
| [6] |
Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function [J]. Nat Rev Genet, 2016, 17(1): 47-62.
|
| [7] |
Wang G, Li Z, Zhao Q, et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway [J]. Oncol Rep, 2014, 31(4): 1839-1845.
|
| [8] |
Zhai H, Fesler A, Schee K, et al. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer [J]. Clin Colorectal Cancer, 2013, 12(4): 261-266.
|
| [9] |
Sanchez Calle A, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer [J]. Cancer Sci, 2018, 109(7): 2093-2100.
|
| [10] |
Tian F, Xu J, Xue F, et al. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma [J]. Biosci Rep, 2017, 37(4): BSR20170301.
|
| [11] |
Martens-Uzunova ES, Böttcher R, Croce CM, et al. Long noncoding RNA in prostate, bladder, and kidney cancer [J]. Eur Urol, 2014, 65(6): 1140-1151.
|
| [12] |
Liu Y, Sharma S, Watabe K. Roles of lncRNA in breast cancer [J]. Front Biosci (Schol Ed), 2015, 7: 94-108.
|
| [13] |
Xu S, Kong D, Chen Q, et al. Oncogenic long noncoding RNA landscape in breast cancer [J]. Mol Cancer, 2017, 16(1): 129.
|
| [14] |
Wang J, Sun J, Yang F. The role of long non-coding RNA H19 in breast cancer [J]. Oncol Lett, 2020, 19(1): 7-16.
|
| [15] |
苗惠，陈健. HOTAIR在乳腺癌中的研究进展 [J]. 中国医药导报，2019, 16(22): 54-57.
|
| [16] |
Zhao L, Kong H, Sun H, et al. LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448 [J]. J Cell Physiol, 2018, 233(5): 4044-4055.
|
| [17] |
Li CY, Liang GY, Yao WZ, et al. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer [J]. Int J Oncol, 2016, 48(5): 1965-1976.
|
| [18] |
Yao J, Xu F, Zhang D, et al. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition [J]. J Cell Biochem, 2018, 119(1): 680-690.
|
| [19] |
Li T, Mo X, Fu L, et al. Molecular mechanisms of long noncoding RNAs on gastric cancer [J]. Oncotarget, 2016, 7(8): 8601-8612.
|
| [20] |
Kretz M. TINCR, staufen1, and cellular differentiation [J]. RNA Biol, 2013, 10(10): 1597-1601.
|
| [21] |
Kretz M, Siprashvili Z, Chu C, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR [J]. Nature, 2013, 493(7431): 231-235.
|
| [22] |
张珊，封国生. 长链非编码RNA TINCR在肿瘤中作用的研究进展 [J]. 中国肿瘤生物治疗杂志，2018, 25(1): 104-108.
|
| [23] |
Dong H, Hu J, Zou K, et al. Activation of LncRNA TINCR by H3K27 acetylation promotes trastuzumab resistance and epithelial-mesenchymal transition by targeting microRNA-125b in breast cancer [J]. Mol Cancer, 2019, 18(1): 3.
|
| [24] |
Xu TP, Liu XX, Xia R, et al. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer [J]. Oncogene, 2015, 34(45): 5648-5661.
|
| [25] |
Zhang ZY, Lu YX, Zhang ZY, et al. Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer [J]. Oncotarget, 2016, 7(16): 22 639-22 649.
|
| [26] |
Beishline K, Azizkhan-Clifford J. Sp1 and the 'hallmarks of cancer’ [J]. FEBS J, 2015, 282(2): 224-258.
|
| [27] |
Liu Y, Du Y, Hu X, et al. Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer [J]. BMC Cancer, 2018, 18(1): 367.
|
| [28] |
Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases [J]. Genes Dev, 1995, 9(10): 1149-1163.
|
| [29] |
徐同鹏. SP1诱导的长非编码RNA TINCR通过调控KLF2 mRNA稳定性影响胃癌细胞的增殖与凋亡 [D]．南京：南京医科大学，2015.
|
| [30] |
吕冰洁，赵洁，郝东，等. SPK1通过调节Bcl-2/Bax途径干扰LLC细胞凋亡 [J]. 中国病理生理杂志，2019, 35(5): 950-954，960.
|
| [31] |
Xu TP, Wang YF, Xiong WL, et al. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis [J]. Cell Death Dis, 2017, 8(6): e2837.
|
| [32] |
Narayan M, Wilken JA, Harris LN, et al. Trastuzumab-induced HER reprogramming in " resistant" breast carcinoma cells [J]. Cancer Res, 2009, 69(6): 2191-2194.
|
| [33] |
Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention [J]. J Exp Clin Cancer Res, 2014, 33(1): 62.
|